Bazedoxifene Acetate

醋酸巴多昔芬

Report date: 2024/08/19 20:00:43
NME

Base Information

Drug NameBazedoxifene Acetate
Drug Alias NameBazedoxifenum醋酸巴多西芬巴多昔芬BazedoxifenoViviant +[10] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsMenopausal symptomsOsteoporosis, PostmenopausalOsteoporosis +[4] 
Global Approved IndicationsOsteoporosis, Postmenopausal
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2009/04/17
Country/TerritoryBelgiumBulgariaCanada +[36] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPending
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncPfizer Europe Ma EeigThe University Of Kansas Medical Center
Inactive CompaniesWyeth LlcAlvogen Korea
Active IndicationsOsteoporosis, PostmenopausalBreast Neoplasms
Inactive IndicationsMenopausal symptomsOsteoporosis

Other Information

ATC CodeG03XC02
Related LinksWikipediaDrugBankKEGG